- Home
- PRHI vs POM Comparison
PRHI vs POM Comparison
Compare PRHI & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRHI | POM |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | China |
| Employees | 9 | N/A |
| Industry | Property-Casualty Insurers | Other Specialty Stores |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2M | 13.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRHI | POM |
|---|---|---|
| Price | $5.25 | $0.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 28.5K | ★ 18.2M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.48 | $0.06 |
| 52 Week High | $2.83 | $6.43 |
Technical Indicators
Market Signals| Indicator | PRHI | POM |
|---|---|---|
| Relative Strength Index (RSI) | 95.42 | 36.81 |
| Support Level | $0.60 | $0.06 |
| Resistance Level | N/A | $0.44 |
| Average True Range (ATR) | 0.12 | 0.02 |
| MACD | 0.31 | 0.00 |
| Stochastic Oscillator | 100.00 | 37.76 |
Price Performance
Historical ComparisonAbout PRHI Presurance Holdings Inc.
Presurance Holdings Inc Formerly Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.